The funds will be used to help train volunteer medical students, who will then be paired with patients referred from palliative care, oncology, family medicine, and social work.
Nitrous oxide鈥攂etter known as "laughing gas"鈥攃an potentially transform treatment for tough-to-beat depression. This centuries-old anesthetic gas targeted specific brain cells in mice and quickly reduced symptoms, according to new research from the Perelman School of Medicine at the University of Pennsylvania, reported today in Nature Communications.
Doylestown Health (DH) officially joined the University of Pennsylvania Health System (UPHS) today, strengthening the two organizations鈥 shared commitment to delivering the most advanced, convenient and compassionate care to patients and families across Philadelphia鈥檚 northern suburbs.
A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.
Adding an anti-obesity medication just one month after behavioral therapy begins鈥攔ather than waiting the currently recommended six months鈥攃an more than double weight loss for patients who struggle initially with lifestyle changes alone, according to new research published in Nature Medicine from a team at the Perelman School of Medicine at the University of Pennsylvania.
We鈥檝e all heard 鈥淐lick It, or Ticket鈥 as a reminder to buckle up in the car, but 鈥淐lick It and Win It!鈥 appears to be an effective approach for sustaining consistent seatbelt use among drivers. When drivers were promised a share of $125 weekly prize money for maintaining perfect seatbelt use streaks, they established good, long-lasting habits. Driving without a seatbelt decreased 26% relative to the control during the incentive program and was 33% than the control even after the program ended, according to research from the Perelman School of Medicine at the University of Pennsylvania, published in the American Journal of Public Health.
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine鈥檚 Abramson Cancer Center.
Distinguished cancer researchers Garrett M. Brodeur, MD, Susan Domchek, MD, Stephan Grupp, MD, PhD, and Robert Vonderheide, MD, DPhil, from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine鈥檚 Abramson Cancer Center have been elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR) Academy.
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses, physical trauma, or other problems can have serious impact on lungs, and when the damage is in the lower regions, traditional treatments, like inhaled medication, might not work.
A Penn Medicine pilot study shows it鈥檚 possible to use digital technology to safely reduce the amount of time some patients with cancer spend receiving care.
Penn Medicine announced a transformative gift from Catherine and Anthony Clifton to usher in a new era of innovation in clinical care, research, and education. edge healthcare for all. In recognition of the gift, the Pavilion at the Hospital of the University of Pennsylvania will be renamed The Clifton Center for Medical Breakthroughs.
PHILADELPHIA 鈥 Over 1000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in , from researchers at the Perelman School of Medicine at the University of Pennsylvania. By creating the most complete and detailed genetic 鈥渕ap鈥 of kidney function to date, the researchers have paved the way for more precise diagnosing of kidney disease, strategies to prevent it, and ways to treat it.
More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious mononucleosis ("mono") and for its association with several cancers and autoimmune diseases. Kidney transplant patients who鈥檝e never been exposed to EBV but receive organs from a donor who carried the virus may develop a life-threatening post-transplant complication called lymphoproliferative disorder (PTLD), according to a new study from the Perelman School of Medicine at the University of Pennsylvania. An estimated 4 to 5 percent of adult kidney transplants 鈥 as many as 1200 patients per year 鈥 could be at risk of the condition, in which the body鈥檚 immune system gets confused and immune cells can grow out of control and act like cancer. The findings were recently published in Annals of Internal Medicine.
Set to enter hospice care, a patient with idiopathic multicentric Castleman鈥檚 disease is now in remission after treatment with a medication identified by an AI-guided analysis
Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society鈥檚 highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award.
Standardizing an assessment process currently used by doctors during care discussions with veterans at risk for suicide in other context could shed more light on the risks related to firearms and opioids.
Pari V. Pandharipande, MD, MPH, FACR, a nationally renowned physician-scientist at The Ohio State University (OSU) College of Medicine and Wexner Medical Center, has been named Chair of the department of Radiology at Penn Medicine, effective June 1, 2025.